CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
CAPRICOR THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$6.65−0.06 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $385.21M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 5, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jun 4, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Mar 31, 2014(first seen in filings) | 1-for-4.25 reverse | Earlier per-share figures multiplied by 4.25 |
| Nov 21, 2013 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |